Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

PGLAF

Progen (PGLAF)

Progen Industries
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PGLAF
DatumZeitQuelleÜberschriftSymbolFirma
16/05/200612h53PR Newswire (US)Progen Prepares for Accelerated Clinical Development of PI-88 Following FDA MeetingNASDAQ:PGLAFProgen Industries
09/08/200513h00PR Newswire (US)Progen Expand PI-88 Clinical Development to Prostate CancerNASDAQ:PGLAF
28/06/200507h28PR Newswire (US)Progen Engages Burrill to Advance PI-88 Partnering DiscussionsNASDAQ:PGLAF
17/05/200506h14PR Newswire (US)Results of PI-88 Phase II Clinical Trial in Melanoma Presented at ASCONASDAQ:PGLAFProgen Industries
27/08/200406h53PR Newswire (US)Progen Reports Solid Financial PerformanceNASDAQ:PGLAFProgen Industries
14/07/200405h36PR Newswire (US)PI-88 Phase II Clinical Trial Targeting Liver Cancer LaunchedNASDAQ:PGLAFProgen Industries
04/05/200404h49PR Newswire (US)U.S. FDA Grants Orphan Drug Status to PI-88 for MelanomaNASDAQ:PGLAF
27/02/200412h00PR Newswire (US)Half Year Report - Progen on Track to Meet MilestonesNASDAQ:PGLAF
11/02/200405h48PR Newswire (US)Progen Commences Third PI-88 Phase II TrialNASDAQ:PGLAFProgen Industries
19/11/200304h20PR Newswire (US)Bonus Issue of Options - Record Date November 28 2003NASDAQ:PGLAFProgen Industries
11/11/200302h58PR Newswire (US)Progen Sharpens Cancer Focus Through DivestmentNASDAQ:PGLAF
31/10/200307h43PR Newswire (US)Progen Industries Limited New Placement Terms AnnouncedNASDAQ:PGLAFProgen Industries
31/10/200307h30PR Newswire (US)Progen Industries Limited Annual General MeetingNASDAQ:PGLAF
29/10/200302h42PR Newswire (US)Progen Granted Anti-Angiogenesis Antibody PatentNASDAQ:PGLAFProgen Industries
 Showing the most relevant articles for your search:NASDAQ:PGLAF